SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-010814
Filing Date
2024-06-11
Accepted
2024-06-11 16:17:37
Documents
1
Group Members
LUIS GOMEZ LAGUNA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 g610240sc13ga1.htm SC 13G/A 44202
  Complete submission text file 0001214659-24-010814.txt   45847
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 241035998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/PINETA 18-B, NAVE 5 CUARTE DE HUERVA (ZARAGOZA) U3 50410
Business Address C/PINETA 18-B, NAVE 5 CUARTE DE HUERVA (ZARAGOZA) U3 50410 34629261560
ODRE 2005 SLU (Filed by) CIK: 0001921938 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U3 | Fiscal Year End: 1231
Type: SC 13G/A